(Q83622849)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352364%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Leveraging biotech's drug discovery expertise for neglected diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352364%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

Joanna E Lowell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352364%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Christopher D Earl

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352364%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352364%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352364%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352364%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352364%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

323-329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352364%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nbt0409-323

25 January 2020

exact match

0 references

cites work

Stage-specific differences in cell cycle control in Trypanosoma brucei revealed by RNA interference of a mitotic cyclin

1 reference

12 December 2020

The involvement of two cdc2-related kinases (CRKs) in Trypanosoma brucei cell cycle regulation and the distinctive stage-specific phenotypes caused by CRK3 depletion

1 reference

12 December 2020

Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote

1 reference

12 December 2020

Protein kinases as drug targets in trypanosomes and Leishmania

1 reference

12 December 2020

Experiments in social responsibility

1 reference

12 December 2020

Global framework on essential health R&D.

1 reference

12 December 2020

Antimalarial drug discovery: old and new approaches

1 reference

12 December 2020

Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase Pfmrk

1 reference

12 December 2020

New drugs for neglected diseases: from pipeline to patients

1 reference

12 December 2020

Drugs for neglected diseases: a failure of the market and a public health failure?

1 reference

12 December 2020

PfPDE1, a novel cGMP-specific phosphodiesterase from the human malaria parasite Plasmodium falciparum

1 reference

12 December 2020

Developing drugs for developing countries

1 reference

12 December 2020

Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug development

1 reference

12 December 2020

The Trypanosoma brucei cAMP phosphodiesterases TbrPDEB1 and TbrPDEB2: flagellar enzymes that are essential for parasite virulence

1 reference

12 December 2020

The origins of new drugs

1 reference

12 December 2020

Designing drugs for parasitic diseases of the developing world

1 reference

12 December 2020

Protein kinase G from pathogenic mycobacteria promotes survival within macrophages

1 reference

12 December 2020

Structural basis for the specific inhibition of protein kinase G, a virulence factor of Mycobacterium tuberculosis

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1038/NBT0409-323

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352364%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference